Internal Medicine, Medical Oncology · Saint Louis, MO
NPI
1033525332
Since 2014
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4921 Parkview Pl, Div Im Medical Oncology, Ste 7a, 7b, 7c
Saint Louis, MO, 63110
Phone (800) 647-2098
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
62,326 services
Medicare patients, 2024
419
Average age 71
Drug cost, 2024
$1.1M
1,391 prescriptions
Company payments, 2025
$44.17
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mia C Weiss was code J9271 (injection, pembrolizumab, 1 mg), 7,400 times for 21 patients. In total Mia C Weiss billed 62,326 services in 133 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,400 | 21 | $43.28 | $320K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,200 | 27 | $0.11 | $760 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,380 | 77 | $0.09 | $123 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 910 | 52 | $0.75 | $686 |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 384 | 25 | $62.89 | $24K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 364 | 13 | $3.73 | $1,357 |
| J9190 Injection, fluorouracil, 500 mg | Office | 281 | 15 | $2.43 | $684 |
| 99213 Office E&M - Established | Office | 246 | 105 | $67.26 | $17K |
| 96413 Chemotherapy Administration | Office | 218 | 138 | $90.00 | $20K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 190 | 12 | $0.29 | $54.71 |
| J9000 Injection, doxorubicin hydrochloride, 10 mg | Office | 179 | 11 | $2.71 | $486 |
| 96367 Intravenous Infusion, Hydration | Office | 164 | 78 | $21.16 | $3,470 |
| 96375 Injection Administration | Office | 161 | 73 | $11.31 | $1,820 |
| 36415 Venipuncture Blood Collection | Office | 88 | 62 | $8.65 | $761 |
| 96372 Injection Administration | Office | 84 | 56 | $10.06 | $845 |
By year: 2022 $2.0M for 102,963 services; 2023 $2.3M for 119,604 services; 2024 $1.2M for 62,326 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 88 | 62 | $8.65 | $761 |
Medicare prescription drug claims, 2024
In 2024, the drug Mia C Weiss prescribed most often to Medicare patients was Oxycodone Hcl, with 98 prescriptions and refills. In total Mia C Weiss wrote 1,391 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 98 | 98 | 40 | $2,282 |
| Ondansetron Hcl Generic | 88 | 90 | 36 | $1,333 |
| Prochlorperazine Maleate Generic | 79 | 81 | 48 | $2,011 |
| Dexamethasone Generic | 71 | 71 | 29 | $687 |
| Imatinib Mesylate Generic | 57 | 64 | 12 | $37K |
| Eliquis Apixaban | 47 | 51 | 11 | $30K |
| Furosemide Generic | 38 | 50 | 13 | $70.44 |
| Potassium Chloride Generic | 36 | 60 | 11 | $1,037 |
| Gabapentin Generic | 36 | 49 | 13 | $356 |
| Prednisone Generic | 35 | 45 | 13 | $68.69 |
| Losartan Potassium Generic | 35 | 57 | Under 11 | $201 |
| Eszopiclone Generic | 30 | 30 | Under 11 | $979 |
| Pazopanib Hcl Generic | 30 | 30 | Under 11 | $274K |
| Olanzapine Generic | 29 | 31 | 12 | $300 |
| Ondansetron Odt Ondansetron | 29 | 29 | 14 | $638 |
Brand drugs: - claims; generic drugs: 1,217 claims; opioid claims: 180.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mia C Weiss $44.17 ($44.17 in general payments such as food, travel and fees) from 5 companies. The largest payer was Aadi Bioscience, Inc. with $44.17.
| Company | Payments | Amount |
|---|---|---|
| Aadi Bioscience, Inc. | 2 | $44.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.